Accelerated Cisplatin-based Chemotherapy for Advanced Bladder Cancer

By Boshoff C.   Oliver R.T.D.   Gallagher C.J.   J. O.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1633-1636

Elsevier

Access to resources Recommend Favorite

A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer

By              

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 855-859

Spandidos Publications

Access to resources Recommend Favorite

Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 299-305

Spandidos Publications

Access to resources Recommend Favorite

Determinants of Response to a Cisplatin-Based Regimen as Neoadjuvant Chemotherapy in Stage IB-IIB Invasive Cervical Cancer

By Bolis G.   van Zainten-Przybysz I.   Scarfone G.   Zanaboni F.   Scarabelli C.   Tateo S.   Calabrese M.   Parazzini F.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 62-65

Academic Press

Access to resources Recommend Favorite

ERCC1 and topoisomerase I expression in small cell lung cancer: Prognostic and predictive implications

By                

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 2104-2110

Spandidos Publications

Access to resources Recommend Favorite